PULMPulmatrix, Inc.
1.380USD-0.72%Mkt Cap: 5.02M USDP/E: Last update: 2026-06-01

Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company…

Indicators:|

Key Statistics

Company
Market Cap5.02M USD
Enterprise Value2.70M USD
Revenue (TTM)
Gross Profit-38.00K USD
Net Income (TTM)-5.16M USD
Revenue/Share
Last Price1.380 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS74584P3010
Valuation
P/E (Trailing)
P/E (Forward)-0.31
PEG
EV/EBITDA
EV/Revenue
P/S
P/B1.92
EPS (TTM)-1.23
EPS (Forward)-4.50
52W Range
1.1603% of range9.230
52W High9.230 USD
52W Low1.160 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-135.49%
ROA-124.72%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-5.43M USD
CapEx (TTM)
FCF Margin
FCF Yield-73.55%
Net Debt-3.32M USD
Net Debt/EBITDA
Balance Sheet
Debt/Equity
Current Ratio4.96
Quick Ratio3.67
Book Value/Sh0.7230 USD
Cash/Share0.9100 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay DateFeb 6, 2019
Splits
Last Split1:20
Split DateMar 1, 2022
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.3.65M
Float3.65M
Insiders0.74%
Institutions9.02%
Short Interest
Short Ratio1.1d
Short % Float0.94%
Short % Out.0.93%
Shares Short33.90K
Short (prev mo.)19.60K
Technical
SMA 501.410 (-2.1%)
SMA 2003.215 (-57.1%)
Beta1.94
S&P 52W Chg27.70%
Avg Vol (30d)24.99K
Avg Vol (10d)19.99K
Technical Indicators
RSI (14)55.0
MACD-0.0131
MACD Signal-0.0392
MACD Hist.+0.0261
BB Upper1.406 USD
BB Middle1.309 USD
BB Lower1.211 USD
BB Width14.94%
ATR (14)0.0816 USD
Vol Ratio (20d)0.67x